T1	Participants 37 76	acromegalic patients with macroadenomas
T2	Participants 273 328	newly diagnosed acromegalic patients with macroadenomas
T3	Participants 840 860	pool of 108 patients
T4	Participants 978 1003	49 patients in each group
T5	Participants 1655 1705	patients with GH-secreting pituitary macroadenomas
